Align Technology, Inc. (BIT:1ALGN)

Market Cap	8.72B
Revenue (ttm)	3.38B
Net Income (ttm)	372.62M
Shares Out	n/a
EPS (ttm)	5.04
PE Ratio	23.41
Forward PE	13.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	57
Open	117.05
Previous Close	117.05
Day's Range	117.05 - 117.05
52-Week Range	112.35 - 173.50
Beta	n/a
RSI	14.27
Earnings Date	Jul 30, 2025

About Ligand Pharmaceuticals

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the...

• Industry: Dental Equipment and Supplies
• Founded: 1997
• Employees: 20,945
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ALGN

Financial Performance

In 2024, Align Technology's revenue was $4.00 billion, an increase of 3.54% compared to the previous year's $3.86 billion. Earnings were $421.36 million, a decrease of -5.32%.